BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15158550)

  • 1. Noncosmetic uses of botulinum toxin.
    Bentsianov B; Zalvan C; Blitzer A
    Clin Dermatol; 2004; 22(1):82-8. PubMed ID: 15158550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Other noncosmetic uses of BOTOX.
    Verheyden J; Blitzer A; Brin MF
    Semin Cutan Med Surg; 2001 Jun; 20(2):121-6. PubMed ID: 11474744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Botulinum toxin. Development for therapeutic purposes].
    Ceballos-Baumann A
    Nervenarzt; 2008 Jun; 79 Suppl 1():3-8. PubMed ID: 18927957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin in ophthalmology.
    Dutton JJ; Fowler AM
    Surv Ophthalmol; 2007; 52(1):13-31. PubMed ID: 17212988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
    Bihari K
    Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on Botulinum Toxin.
    Carruthers A
    Skin Therapy Lett; 1999; 4(5):1-2. PubMed ID: 10751835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin in primary care medicine.
    Felber ES
    J Am Osteopath Assoc; 2006 Oct; 106(10):609-14. PubMed ID: 17122031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox.
    Badarny S; Susel Z; Honigman S
    Isr Med Assoc J; 2008 Jul; 10(7):520-2. PubMed ID: 18751631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is new in the era of focal dystonia treatment? Botulinum injections and more.
    Cetinkaya A; Brannan PA
    Curr Opin Ophthalmol; 2007 Sep; 18(5):424-9. PubMed ID: 17700237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and future botulinum neurotoxin type A preparations in aesthetics: a literature review.
    Sattler G
    J Drugs Dermatol; 2010 Sep; 9(9):1065-71. PubMed ID: 20865836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin: basic science and clinical uses in otolaryngology.
    Blitzer A; Sulica L
    Laryngoscope; 2001 Feb; 111(2):218-26. PubMed ID: 11210864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases.
    Coté TR; Mohan AK; Polder JA; Walton MK; Braun MM
    J Am Acad Dermatol; 2005 Sep; 53(3):407-15. PubMed ID: 16112345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical application of botulinum toxin in otolaryngology, head and neck practice (brief review).
    Yin S; Stucker FJ; Nathan CO
    J La State Med Soc; 2001 Feb; 153(2):92-7. PubMed ID: 11261363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding use of botulinum toxin.
    Bhidayasiri R; Truong DD
    J Neurol Sci; 2005 Aug; 235(1-2):1-9. PubMed ID: 15990116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxins for facial wrinkles: beyond glabellar lines.
    Dayan SH; Maas CS
    Facial Plast Surg Clin North Am; 2007 Feb; 15(1):41-9, vi. PubMed ID: 17317554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of botulinum toxin therapy in otorhinolaryngology: experience from 1,000 treatments.
    Helmstaedter V; Wittekindt C; Huttenbrink KB; Guntinas-Lichius O
    Laryngoscope; 2008 May; 118(5):790-6. PubMed ID: 18300708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal case of BOTOX-related anaphylaxis?
    Li M; Goldberger BA; Hopkins C
    J Forensic Sci; 2005 Jan; 50(1):169-72. PubMed ID: 15831014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of botulinum toxin to clinical therapy: advances and cautions.
    Levy NS; Lowenthal DT
    Am J Ther; 2012 Jul; 19(4):281-6. PubMed ID: 22481607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.